Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pilot Safety and Exploratory Efficacy of PSC-05 for the Treatment of Chronic Mild Traumatic Brain Injury
Sponsor: Personalized Stem Cells, Inc.
Summary
This study is a pilot single arm, Phase 1b study of the safety and preliminary efficacy of PSC-05, an adipose-derived autologous mesenchymal stem cell for the treatment of chronic mTBI. This study will focus on United States military special forces operators.
Official title: Pilot Safety and Exploratory Efficacy of PSC-05, An Autologous Adipose-Derived Stem Cell Therapy Product, for the Treatment of Chronic Mild Traumatic Brain Injury
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2026-11-01
Completion Date
2027-07-31
Last Updated
2026-11-06
Healthy Volunteers
No
Conditions
Interventions
autologous adipose-derived stem cells
culture-expanded adipose stem cells
Locations (1)
DISC Surgery Center
Carlsbad, California, United States